Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma
Abstract DNA damage resistance is a major barrier to effective DNA-damaging therapy in multiple myeloma (MM). To discover mechanisms through which MM cells overcome DNA damage, we investigate how MM cells become resistant to antisense oligonucleotide (ASO) therapy targeting Interleukin enhancer bind...
Main Authors: | Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Christopher Jackson, Ashley Rose, Ken Furudate, Bethany Wildeman, Matteo Marchesini, Valentina Marchica, Paola Storti, Giannalisa Todaro, Irene Ganan-Gomez, Vera Adema, Juan Jose Rodriguez-Sevilla, Yun Qing, Min Jin Ha, Rodrigo Fonseca, Caleb Stein, Caleb Class, Lin Tan, Sergio Attanasio, Guillermo Garcia-Manero, Nicola Giuliani, David Berrios Nolasco, Andrea Santoni, Claudio Cerchione, Carlos Bueso-Ramos, Marina Konopleva, Philip Lorenzi, Koichi Takahashi, Elisabet Manasanch, Gabriella Sammarelli, Rashmi Kanagal-Shamanna, Andrea Viale, Marta Chesi, Simona Colla |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-45350-8 |
Similar Items
-
S185: TARGETING DNA2 OVERCOMES METABOLIC REPROGRAMMING IN 1Q21 MULTIPLE MYELOMA
by: Natthakan Thongon, et al.
Published: (2023-08-01) -
Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets
by: Jessica Burroughs Garcìa, et al.
Published: (2021-06-01) -
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma
by: Martina Manzoni, et al.
Published: (2020-05-01) -
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes
by: Juan Jose Rodriguez-Sevilla, et al.
Published: (2024-03-01) -
Hematopoiesis under telomere attrition at the single-cell resolution
by: Natthakan Thongon, et al.
Published: (2021-11-01)